GSA Capital Partners’s Tenaya Therapeutics TNYA Stock Holding History

GSA Capital Partners’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$743K	Sell	1,072,911 -405,701	-27%	-$299K	0.05%	652
2025 Q4	$1.05M	Buy	1,478,612 +1,016,808	+220%	+$1.38M	0.09%	332
2025 Q3	$748K	Buy	+461,804	New	+$465K	0.06%	590
2024 Q4	–	Sell	-147,932	Closed	-$286K	–	2032
2024 Q3	$286K	Sell	147,932 -34,130	-19%	-$96.4K	0.02%	1241
2024 Q2	$564K	Sell	182,062 -41,989	-19%	-$173K	0.04%	880
2024 Q1	$1.17M	Sell	224,051 -246,794	-52%	-$1.18M	0.09%	343
2023 Q4	$1.53M	Buy	470,845 +107,352	+30%	+$232K	0.13%	214
2023 Q3	$927K	Buy	363,493 +240,082	+195%	+$1.01M	0.08%	441
2023 Q2	$724K	Buy	123,411 +35,243	+40%	+$205K	0.07%	508
2023 Q1	$251K	Buy	+88,168	New	+$248K	0.02%	1129
2022 Q4	–	Sell	-62,666	Closed	-$182K	–	1892
2022 Q3	$182K	Buy	+62,666	New	+$292K	0.02%	1257

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GSA Capital Partners's TNYA Position: Q1 2026 in Review

GSA Capital Partners reduced its Tenaya Therapeutics (TNYA) stake by 27% in Q1 2026, selling an estimated $299K and leaving 1,072,911 shares worth $743K. The position accounts for 0.05% of the portfolio, ranked #652.

GSA Capital Partners first reported a position in TNYA in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.53M in Q4 2023. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

GSA Capital Partners held 1,072,911 shares of Tenaya Therapeutics worth $743K as of Q1 2026.
GSA Capital Partners sold 405,701 Tenaya Therapeutics shares in Q1 2026, an estimated $299K.
Tenaya Therapeutics made up 0.05% of GSA Capital Partners's portfolio in Q1 2026, its #652 holding.
GSA Capital Partners first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 11 quarters since.
GSA Capital Partners's Tenaya Therapeutics position peaked at $1.53M in Q4 2023.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.